van Thienen Johannes V, Fledderus Joost O, Dekker Rob J, Rohlena Jakub, van Ijzendoorn Gerben A, Kootstra Neeltje A, Pannekoek Hans, Horrevoets Anton J G
Department of Medical Biochemistry, Academic Medical Center, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.
Cardiovasc Res. 2006 Nov 1;72(2):231-40. doi: 10.1016/j.cardiores.2006.07.008. Epub 2006 Jul 12.
The transcription factor KLF2 is considered an important mediator of the anti-inflammatory and anti-thrombotic properties of the endothelium. KLF2 is absent from low-shear, atherosclerosis-prone sites of the vascular tree but is induced by HMG-CoA reductase inhibitors (statins) in vitro. We studied KLF2-dependent induction of important determinants of the atheroprotective status of the endothelium to determine whether pharmacological intervention, e.g. by statins, can potentially replace shear stress.
Shear stress and statin effects in combination with TNF-alpha were determined in human umbilical vein endothelial cells by quantitative measurements of the steady-state levels and stability of mRNA for KLF2 and its downstream target genes thrombomodulin (TM) and endothelial nitric oxide synthase (eNOS).
We demonstrate that prolonged shear stress has a potential that is superior to that of statins to induce the KLF2-dependent expression of eNOS and TM, especially in the presence of the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha). These effects can be attributed to the sustained stabilization of KLF2 mRNA by shear, leading to an increased KLF2 protein expression and concomitant strong induction of KLF2 downstream targets. The stabilization of KLF2 mRNA is demonstrated to be dependent on signaling involving phosphoinositide 3-kinase (PI3K).
The stabilization of KLF2 steady-state levels, as induced by prolonged shear stress but not by statins, may be essential for sustaining the quiescent, atheroprotective status of the vascular endothelium under inflammatory conditions.
转录因子KLF2被认为是内皮细胞抗炎和抗血栓形成特性的重要介质。在血管树中低剪切力、易发生动脉粥样硬化的部位不存在KLF2,但在体外它可被HMG-CoA还原酶抑制剂(他汀类药物)诱导产生。我们研究了KLF2依赖性诱导内皮细胞抗动脉粥样硬化状态的重要决定因素,以确定药物干预(如使用他汀类药物)是否有可能替代剪切应力。
通过定量测量KLF2及其下游靶基因血栓调节蛋白(TM)和内皮型一氧化氮合酶(eNOS)的mRNA稳态水平和稳定性,在人脐静脉内皮细胞中测定剪切应力和他汀类药物与肿瘤坏死因子-α(TNF-α)联合作用的效果。
我们证明,长时间的剪切应力在诱导eNOS和TM的KLF2依赖性表达方面,其潜力优于他汀类药物,尤其是在存在促炎细胞因子肿瘤坏死因子-α(TNF-α)的情况下。这些作用可归因于剪切力对KLF2 mRNA的持续稳定作用,导致KLF2蛋白表达增加,并伴随KLF2下游靶点的强烈诱导。KLF2 mRNA的稳定作用被证明依赖于涉及磷脂酰肌醇3激酶(PI3K)的信号传导。
长时间剪切应力而非他汀类药物诱导的KLF2稳态水平的稳定,对于在炎症条件下维持血管内皮细胞的静止、抗动脉粥样硬化状态可能至关重要。